On October 14, 2015, Judge Rudolph Contreras of the District Court for the District Court of Columbia sided with drugmakers in a decision that narrowed the scope of 340B, a popular but controversial drug discount program. The decision effectively bars children’s hospitals, cancer hospitals, and rural hospitals from obtaining 340B […]

By: Nawa Arsala In a widely-criticized and controversial move, Martin Shkreli of Turing Pharmaceuticals increased the price of the drug Daraprim from $13.50 a tablet to $750. That is 5,455% more expensive than it was only two months ago. The seemingly overnight price increase has caused waves in the political […]

On Monday, October 5th, just a little over the week before the deadline, Governor Jerry Brown signed into California state law the End of Life Option Act.  The act would allow adults suffering from a qualified terminal illness to be prescribed a life-ending drug.  On September 14th, the California Legislature passed […]

Health care professionals are constantly developing and brainstorming innovative ways to increase access to healthcare in an affordable way. Is telemedicine the solution to the health care industry’s problems? The American Telemedicine Association defines telemedicine as the “use of medical information exchanged from one site to another via electronic communications […]